These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1281397

  • 21. Treatment of advanced Hodgkin's disease.
    Straus DJ.
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):287-302. PubMed ID: 2473061
    [Abstract] [Full Text] [Related]

  • 22. Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
    Straus DJ, Myers J, Koziner B, Lee BJ, Clarkson BD.
    Cancer Chemother Pharmacol; 1983 Jun; 11(2):80-5. PubMed ID: 6194913
    [Abstract] [Full Text] [Related]

  • 23. Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
    Bonadonna G, Viviani S, Bonfante V, Gianni AM, Valagussa P.
    Eur J Cancer; 2005 May; 41(7):998-1006. PubMed ID: 15862748
    [Abstract] [Full Text] [Related]

  • 24. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P, Abate G, Fiore M, Di Finizio G, Frezza P, Scoppa G, Anania C, Coucourde F, Zarrilli D.
    J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract] [Full Text] [Related]

  • 25. [Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine)].
    Komarnicki M, Balcerzak A, Górski P, Pawlak L, Hansz J.
    Acta Haematol Pol; 1994 Jul; 25(4):363-8. PubMed ID: 7531381
    [Abstract] [Full Text] [Related]

  • 26. Combination chemotherapy with alternating MOPP-ABVD in advanced Hodgkin's disease.
    Brusamolino E, Lazzarino M, Morra E, Inverardi D, Merante S, Castelli G, Canevari A, Dornini G, Bernasconi C.
    Haematologica; 1989 Jul; 74(2):173-9. PubMed ID: 2473013
    [Abstract] [Full Text] [Related]

  • 27. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 May 01; 21(9):1734-9. PubMed ID: 12721249
    [Abstract] [Full Text] [Related]

  • 28. Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie.
    Raemaekers J, Burgers M, Henry-Amar M, Pinna A, Mandard A, Monfardini S, Hagenbeek A, Breed W, Carde P, Vovk M, van Hoof A, Thomas J, Noordijk E.
    Ann Oncol; 1997 May 01; 8 Suppl 1():111-4. PubMed ID: 9187443
    [Abstract] [Full Text] [Related]

  • 29. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS.
    J Clin Oncol; 1998 Mar 01; 16(3):1235. PubMed ID: 9508214
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy.
    Chan PD, Berk MA, Kucuk O, Singh S.
    Med Pediatr Oncol; 1992 Mar 01; 20(4):345-8. PubMed ID: 1376855
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial.
    Fermé C, Sebban C, Hennequin C, Diviné M, Lederlin P, Gabarre J, Ferrant A, Caillot D, Bordessoule D, Brice P, Moullet I, Berger F, Lepage E.
    Blood; 2000 Apr 01; 95(7):2246-52. PubMed ID: 10733492
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome].
    Baron F, Hermanne JP, Fassotte MF, Beguin Y, Fillet G.
    Rev Med Liege; 1998 Nov 01; 53(11):651-3. PubMed ID: 9887654
    [Abstract] [Full Text] [Related]

  • 39. Secondary uncommon solid neoplasms in cured Hodgkin's disease and follow-up of the original B-DOPA chemotherapy patient group.
    Lokich JJ.
    Am J Clin Oncol; 1990 Jun 01; 13(3):247-50. PubMed ID: 1693259
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.